16th International Symposium on Purine and Pyrimidine Metabolism in Man

June 6-9, 2015 – Columbia University, New York City

Inhibitors of lactate dehydrogenase overcome the resistance towards gemcitabine in hypoxic mesothelioma cells, and modulate the expression of the human equilibrative transporter-1 (hENT1)

Elisa Giovannetti, Leticia G. Leon, Paolo A. Zucali, Filippo Minutolo, Godefridus J Peters

This work was partially supported by grants from “The Law Offices of Peter G. Angelos Grant” from the Mesothelioma Applied Research Foundation (E.G, L.G.L, F.M., G.J.P), EORTC-PAMM (G.J.P, E.G., F.M.), Clinical Research and Innovationscouting” from the University of Pisa (E.G., F.M.), Fondazione Humanitas (E.G, P.A.Z), AIRC/Start-Up (E.G.), European Union Seventh Framework Program [FP7/2007-2013] under grant agreement n° PIIF-GA-2011-299026 (F.M.), and FP7-REGPOT-2012-CT2012-31637-IMBRAIN (L.G.L., E.G., G.J.P.)

Website: www.pps2015.org

Pdf: Inhibitors at 16th International Symposium PPS